Laia Monserrat
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Modulation of splicing factors SF3B1 and SRSF1 by polypurine reverse Hoogsteen hairpins affects the splicing pattern of estrogen receptor α in breast cancer cells.
Journal: Cancer cell international
Published: January 30, 2026
Determinants of long-term response to patritumab deruxtecan in breast cancer patient-derived xenografts.
Journal: NPJ precision oncology
Published: June 17, 2025
Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination-Deficient Breast Cancer.
Journal: Cancer research
Published: July 23, 2024
USP10/GSK3β-mediated inhibition of PTEN drives resistance to PI3K inhibitors in breast cancer.
Journal: The Journal of clinical investigation
Published: March 27, 2024
Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer.
Journal: Nature communications
Published: November 14, 2022
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer.
Journal: Nature communications
Published: February 22, 2021
Genetic Alterations in the PI3K/AKT Pathway and Baseline AKT Activity Define AKT Inhibitor Sensitivity in Breast Cancer Patient-derived Xenografts.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 09, 2019
Direct CDKN2 Modulation of CDK4 Alters Target Engagement of CDK4 Inhibitor Drugs.
Journal: Molecular cancer therapeutics
Published: July 09, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026